References
- Balasse E. O. Effets de la fenfluramine administrée à court terme ou a long terme sur la lipolyse du sujet obèse. Colloque International sur la Fenfluramine. La Vie Médicale au Canada Franĉais, Montreal 1972; 46–511. Balasse E. O. Effets de la fenfluramine administrée à court terme ou a long terme sur la lipolyse du sujet obèse. Colloque International sur la Fenfluramine. La Vie Médicale au Canada Franĉais, Montreal 1972; 46–51
- Butterfield W. J. H., Whichelow M. J. Effects of fenfluramine on peripheral glucose metabolism in man. “Amphetamines and Related Compounds”, E. Costa, S. Garattini. Raven Press, New York 1970; 611–6182. Butterfield W. J. H., Whichelow M. J. Effects of fenfluramine on peripheral glucose metabolism in man. “Amphetamines and Related Compounds”, E. Costa, S. Garattini. Raven Press, New York 1970; 611–618
- Galloway D. B., Logie A. W., Petrie J. C. Prolonged-action fenfluramine in non-diabetic patients with refractory obesity. Postgrad. Med. J. 1975; 51: 155, Suppl. 13. Galloway D. B., Logie A. W., Petrie J. C. Prolonged-action fenfluramine in non-diabetic patients with refractory obesity. Postgrad. Med. J. 1975; 51: 155, Suppl. 1
- Galton D. J., Wilson J. P. D. The effects of drugs on lipogenesis from glucose and palmitate in human adipose tissue. Horm. Metabol. Res. 1971; 3: 2624. Galton D. J., Wilson J. P. D. The effects of drugs on lipogenesis from glucose and palmitate in human adipose tissue. Horm. Metabol. Res. 1971; 3: 262
- Hooper A. C. A clinical trial of a new fenfluramine preparation (Ponderax, P.A. Caps). Postgrad. Med. J. 1975; 51: 159, Suppl. 15. Hooper A. C. A clinical trial of a new fenfluramine preparation (Ponderax, P.A. Caps). Postgrad. Med. J. 1975; 51: 159, Suppl. 1
- Munro J. F., Seaton D. A., Duncan L. J. P. Treatment of refractory obesity with fenfluramine. Br. Med. J. 1966; 2: 6246. Munro J. F., Seaton D. A., Duncan L. J. P. Treatment of refractory obesity with fenfluramine. Br. Med. J. 1966; 2: 624
- Oswald I., Jones H. S., Mannerheim J. E. The effects of two slimming drugs on sleep. Br. Med. J. 1968; 1: 7967. Oswald I., Jones H. S., Mannerheim J. E. The effects of two slimming drugs on sleep. Br. Med. J. 1968; 1: 796
- Raich W. A., Rickels K., Raab E. A double-blind evaluation of fenfluramine in obese somatising neurotic medical clinic patients. Curr. Ther. Res. 1966; 8: 318. Raich W. A., Rickels K., Raab E. A double-blind evaluation of fenfluramine in obese somatising neurotic medical clinic patients. Curr. Ther. Res. 1966; 8: 31
- Spence A. W., Medvei V. C. Trifluethamine in a treatment of obesity. Br. J. Clin. Pract. 1966; 20: 6439. Spence A. W., Medvei V. C. Trifluethamine in a treatment of obesity. Br. J. Clin. Pract. 1966; 20: 643
- Strong J. A., Lawson A. A. H. Double-blind crossover trial of fenfluramine and metformin in the treatment of obesity. “Amphetamines and Related Compounds”, E. Costa, S. Garattini. Raven Press, New York 1970; 673–68310. Strong J. A., Lawson A. A. H. Double-blind crossover trial of fenfluramine and metformin in the treatment of obesity. “Amphetamines and Related Compounds”, E. Costa, S. Garattini. Raven Press, New York 1970; 673–683
- Tozer R., Leivers P. G., Campbell D. B., Edwards J. A. Bioavailability of prolonged action fenfluramine. Postgrad. Med. J. 1975; 51: 151, Suppl. 111. Tozer R., Leivers P. G., Campbell D. B., Edwards J. A. Bioavailability of prolonged action fenfluramine. Postgrad. Med. J. 1975; 51: 151, Suppl. 1
- Turtle J. T., Burgess J. A., Bauckan S. The metabolic effects of fenfluramine. S. Afr. Med. J. 1971; 45: 22, Suppl.12. Turtle J. T., Burgess J. A., Bauckan S. The metabolic effects of fenfluramine. S. Afr. Med. J. 1971; 45: 22, Suppl.